|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02162 KEYMED BIO-B
Nominal 
57.500 -1.950 (-3.280%) Ranking Overview
Ranking based on 8 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
8
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | -197.00 RMB (cts) | |
| Net Profit | -515.24 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | -521.00 | -174.05 | 0 | -- | -411.20 | -681.41 |
| 2026 | -482.00 | -167.90 | 0 | -- | -117.00 | -905.99 |
| 2027 | 58.00 | 19.50 | 0 | -- | 405.00 | -700.11 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | -681.41 | -244.00 | -- | MORGAN STANLEY | Overweight | 93.50 | 21/09/2025 | |
| 2025 | -411.20 | -157.00 | -- | GOLDMAN SACHS | Buy | 92.67 | 02/11/2025 | |
| 2025 | -679.40 | -227.00 | -- | HUATAI FIN HLDGS HK | Buy | 91.08 | 05/11/2025 | |
| 2025 | -518.00 | -173.10 | -- | CITIGROUP | Buy | 85.00 | 28/08/2025 | |
| 2025 | -524.00 | -175.00 | -- | CICC | Outperform | 85.00 | 27/08/2025 | |
| 2025 | -455.00 | -162.50 | -- | CLSA | OutPerform | 78.00 | 28/08/2025 | |
| 2025 | -487.00 | -168.50 | -- | BOCOM | Buy | 78.00 | 28/08/2025 | |
| 2025 | -573.00 | -205.00 | -- | SPDB INT'L SEC | Buy | 77.00 | 29/08/2025 | |
| 2026 | -905.99 | -324.00 | -- | MORGAN STANLEY | -- | -- | 21/09/2025 | |
| 2026 | -141.70 | -54.00 | -- | GOLDMAN SACHS | -- | -- | 02/11/2025 | |
| 2026 | -669.87 | -224.00 | -- | HUATAI FIN HLDGS HK | -- | -- | 05/11/2025 | |
| 2026 | -775.00 | -260.00 | -- | CICC | -- | -- | 27/08/2025 | |
| 2026 | -406.00 | -135.80 | -- | CITIGROUP | -- | -- | 28/08/2025 | |
| 2026 | -117.00 | -39.20 | -- | BOCOM | -- | -- | 28/08/2025 | |
| 2026 | -274.00 | -98.00 | -- | CLSA | -- | -- | 28/08/2025 | |
| 2026 | -558.00 | -200.00 | -- | SPDB INT'L SEC | -- | -- | 29/08/2025 | |
| 2027 | -700.11 | -250.00 | -- | MORGAN STANLEY | -- | -- | 21/09/2025 | |
| 2027 | 195.80 | 75.00 | -- | GOLDMAN SACHS | -- | -- | 02/11/2025 | |
| 2027 | -282.40 | -95.00 | -- | HUATAI FIN HLDGS HK | -- | -- | 05/11/2025 | |
| 2027 | 58.00 | 19.50 | -- | CITIGROUP | -- | -- | 28/08/2025 | |
| 2027 | 405.00 | 135.40 | -- | BOCOM | -- | -- | 28/08/2025 | |
| 2027 | 272.00 | 97.20 | -- | CLSA | -- | -- | 28/08/2025 | |
| 2027 | -420.00 | -150.00 | -- | SPDB INT'L SEC | -- | -- | 29/08/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 07/11/2025 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |